What is the current valuation of the US digital pathology market as of 2024?

The US digital pathology market was valued at 275.1 $ Million in 2024. Read More

What is the projected market valuation for the US digital pathology market in 2035?

The projected valuation for the US digital pathology market in 2035 is 528.32 $ Million. Read More

What is the expected CAGR for the US digital pathology market during the forecast period 2025 - 2035?

The expected CAGR for the US digital pathology market during the forecast period 2025 - 2035 is 6.11 %. Read More

Which technology segments are driving growth in the US digital pathology market?

The technology segments driving growth include Whole Slide Imaging, Virtual Microscopy, and Artificial Intelligence, with valuations of 240.0 $ Million, 160.0 $ Million, and 128.32 $ Million respectively by 2035. Read More

What applications are contributing to the US digital pathology market's expansion?

Key applications contributing to market expansion include Cancer Diagnosis, Research and Development, and Education, projected to reach 210.0 $ Million, 150.0 $ Million, and 168.32 $ Million respectively by 2035. Read More

Who are the key players in the US digital pathology market?

Key players in the US digital pathology market include Philips, Roche, Danaher, Leica Biosystems, 3DHISTECH, Sectra, Huron Digital Pathology, OptraHEALTH, and PathAI. Read More

What are the primary end-user segments in the US digital pathology market?

Primary end-user segments include Hospitals, Diagnostic Laboratories, and Research Institutes, with projected valuations of 210.0 $ Million, 180.0 $ Million, and 138.32 $ Million respectively by 2035. Read More

What components are essential in the US digital pathology market?

Essential components in the US digital pathology market include Software, Hardware, and Services, with projected valuations of 158.5 $ Million, 105.2 $ Million, and 264.6 $ Million respectively by 2035. Read More

How does the US digital pathology market compare to other regions?

While specific regional comparisons are not provided, the US digital pathology market is characterized by robust growth driven by technological advancements and increasing adoption in healthcare. Read More

What trends are influencing the US digital pathology market in 2025?

Trends influencing the US digital pathology market in 2025 include advancements in AI technology, increasing demand for efficient diagnostic solutions, and a growing focus on research and education. Read More

US Digital Pathology Market

US Digital Pathology Market Research Report: Size, Share, Trend Analysis By Technology (Whole Slide Imaging, Digital Scanners, Image Analysis Software, Telepathology), By Applications (Diagnostics, Research, Education, Drug Discovery), By End Use (Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies) and By Product (Hardware, Software, Services) - Growth Outlook & Industry Forecast 2025 To 2035

Forecast Period

2025 - 2035

CAGR

6.11%

2024 Market Size

$ 275.1 Million

2035 Market Size

$ 528.32 Million

Medical Device ● Updated July 2026 Report ID: MRFR/MED/18080-HCR | Pages: 100 | Author: Nidhi Mandole, Garvit Vyas

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Life Sciences, BY Technology (USD Million)
  1. 4.1.1 Whole Slide Imaging
  2. 4.1.2 Virtual Microscopy
  3. 4.1.3 Artificial Intelligence
2. 4.2 Life Sciences, BY Application (USD Million)
  1. 4.2.1 Cancer Diagnosis
  2. 4.2.2 Research and Development
  3. 4.2.3 Education
3. 4.3 Life Sciences, BY End User (USD Million)
  1. 4.3.1 Hospitals
  2. 4.3.2 Diagnostic Laboratories
  3. 4.3.3 Research Institutes
4. 4.4 Life Sciences, BY Component (USD Million)
  1. 4.4.1 Software
  2. 4.4.2 Hardware
  3. 4.4.3 Services
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Life Sciences
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Life Sciences
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Philips (NL)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Roche (CH)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Danaher (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Leica Biosystems (DE)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 3DHISTECH (HU)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Sectra (SE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Huron Digital Pathology (CA)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 OptraHEALTH (IN)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 PathAI (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 US MARKET ANALYSIS BY TECHNOLOGY
3. 6.3 US MARKET ANALYSIS BY APPLICATION
4. 6.4 US MARKET ANALYSIS BY END USER
5. 6.5 US MARKET ANALYSIS BY COMPONENT
6. 6.6 KEY BUYING CRITERIA OF LIFE SCIENCES
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF LIFE SCIENCES
9. 6.9 DRIVERS IMPACT ANALYSIS: LIFE SCIENCES
10. 6.10 RESTRAINTS IMPACT ANALYSIS: LIFE SCIENCES
11. 6.11 SUPPLY / VALUE CHAIN: LIFE SCIENCES
12. 6.12 LIFE SCIENCES, BY TECHNOLOGY, 2024 (% SHARE)
13. 6.13 LIFE SCIENCES, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
14. 6.14 LIFE SCIENCES, BY APPLICATION, 2024 (% SHARE)
15. 6.15 LIFE SCIENCES, BY APPLICATION, 2024 TO 2035 (USD Million)
16. 6.16 LIFE SCIENCES, BY END USER, 2024 (% SHARE)
17. 6.17 LIFE SCIENCES, BY END USER, 2024 TO 2035 (USD Million)
18. 6.18 LIFE SCIENCES, BY COMPONENT, 2024 (% SHARE)
19. 6.19 LIFE SCIENCES, BY COMPONENT, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TECHNOLOGY, 2025-2035 (USD Million)
  2. 7.2.2 BY APPLICATION, 2025-2035 (USD Million)
  3. 7.2.3 BY END USER, 2025-2035 (USD Million)
  4. 7.2.4 BY COMPONENT, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

US Digital Pathology Market Segmentation

US Digital Pathology Market By Technology (USD Million, 2025-2035)

Whole Slide Imaging
Virtual Microscopy
Artificial Intelligence

US Digital Pathology Market By Application (USD Million, 2025-2035)

Cancer Diagnosis
Research and Development
Education

US Digital Pathology Market By End User (USD Million, 2025-2035)

Hospitals
Diagnostic Laboratories
Research Institutes

US Digital Pathology Market By Component (USD Million, 2025-2035)

Software
Hardware
Services

Certified Researchers

Customize Report

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”